Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways

The aim of the present study is to elucidate the neuronal pathways associated to NSAIDs causing a reduction of the risk and progression of Alzheimer's disease. The research was developed administering the active enantiomer of ibuprofen, dexibuprofen (DXI), in order to reduce associated gastric...

Descripción completa

Detalles Bibliográficos
Autores principales: Ettcheto, Miren, Sánchez-López, Elena, Pons, Laura, Busquets, Oriol, Olloquequi, Jordi, Beas-Zarate, Carlos, Pallas, Merce, García, Maria Luisa, Auladell, Carme, Folch, Jaume, Camins, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480981/
https://www.ncbi.nlm.nih.gov/pubmed/28646794
http://dx.doi.org/10.1016/j.redox.2017.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480981/
https://www.ncbi.nlm.nih.gov/pubmed/28646794
http://dx.doi.org/10.1016/j.redox.2017.06.003

Ejemplares similares